WEDNESDAY, April 26, 2023 (HealthDay News) — An extended-release version of a Parkinson’s disease drug could provide more stable relief for patients with the movement disorder, new clinical trial data show. The new formulation of levodopa, called IPX203, extended the duration of patients’ “on time” — the amount of timeContinue Reading

WEDNESDAY, March 22, 2023 (HealthDay News) — Exercise can help improve movement-related symptoms for people who have Parkinson’s disease, a new review finds. And any type of structured exercise is better than none, researchers added. The findings were published recently in the Cochrane Reviews. “Parkinson’s disease cannot be cured, butContinue Reading

WEDNESDAY, March 8, 2023 (HealthDay News) — Some people may have a gene that helps protect them from respiratory diseases like COVID-19 — and helped their ancestors fight the plague. It comes at a cost. This same gene variation may be linked to an increased risk of autoimmune disease, includingContinue Reading